Efficacy of Erlotinib in patients (PTS) with advanced non-small-cell lung cancer (NSCLC) relative to clinical charesteristics : subset analyses from the trust study
R. Pirker , G. Scagliotti , A. Franke , Léon Bosquee
American Journal of Clinical Oncology 26 ( 20)
2008
Expression of the multidrug resistance protein (MRP1) in breast cancer.
M Filipits , R Malayeri , RW Suchomel , G Pohl
Anticancer Research 19 5043 -5049
30
1999
Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein.
R. Pirker , M. Barancik , J. Wallner , Z. Sulova
Neoplasma 39 ( 2) 73 -77
38
1992
Clinical relevance of drug resistance genes in malignant disease.
M Filipits , RW Suchomel , S Zöchbauer , R Malayeri
Leukemia 10
26
1996
P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia.
R. Pirker , K. Lechner , P. A. Kyrle , S. Zochbauer
Leukemia 8 ( 6) 974 -977
88
1994
MDR1 RNA EXPRESSION IS AN INDEPENDENT PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA. AUTHOR'S REPLIES
R. Pirker , M. Gotzl , K. Lechner , J. Wallner
Blood 80 ( 2) 558 -559
1
1992
Immunotoxins active against human ovarian cancer cell lines
R. Pirker , A. Frankel , D. FitzGerald
1985
JICC01.07 Oral VEGFR Inhibitor Monotherapy for Lung Cancer: Should We or Should We Not?
R. Pirker
Journal of Thoracic Oncology 16 ( 3)
2021
Prognostic value of class III b-tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin-based chemotherapy (CT): A validation study on three randomized trials
T. Reiman , P. Seve , A. Vataire , A. Dunant
Journal of Clinical Oncology 26 7506 -7506
6
2008
FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)
R. Pirker , A. Szczesna , J. von Pawel , M. Krzakowski
Journal of Clinical Oncology 26 3 -3
159
2008
Dexverapamil as resistance modifier in acute myeloid leukaemia
R. Pirker , S. Zöchbauer , H. Kupper , A. Laßmann
Journal of Cancer Research and Clinical Oncology 121 ( 3)
7
1995
A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer
R. Pirker , J. Vansteenkiste , J. Gateley , P. Yates
European Journal of Cancer 37
33
2001
Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC): Data from the FLEX study
K. J. O'Byrne , I. Bondarenko , C. Barrios , C. Eschbach
Journal of Clinical Oncology 27 8007 -8007
88
2009
Prognostic factors in advanced NSCLC: Experience from the FLEX trial
R. Pirker , J. Rodrigues-Pereira , A. Szczesna , J. Von Pawel
Journal of Clinical Oncology 27 ( 15_suppl) 8083 -8083
3
2009
Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline
G. Rossi , R. Pirker , J. Vansteenkiste , D. Tomita
Supportive Care in Cancer 12 ( 4) 253 -262
32
2004
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial
C. Manegold , U. Gatzemeier , J. von Pawel , R. Pirker
Annals of Oncology 11 ( 4) 435 -440
149
2000
A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease)
R. Pirker , E. Ulsperger , K. Aigner , J. Messner
Journal of Clinical Oncology 22 7216 -7216
3
2004
MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
R. Pirker , J. Wallner , K. Geissler , W. Linkesch
Journal of the National Cancer Institute 83 ( 10) 708 -712
478
1991
D-dimer levels and prediction of overall survival in cancer patients.
C. Ay , D. Dunkler , R. Vormittag , P. Quehenberger
Journal of Clinical Oncology 28 ( 15_suppl) 10587 -10587
2010
VEGF and EGFR inhibition: opening a new door to cancer treatment
W. Scheithauer , R. Pirker , T. Grünberger , G. Kornek
European Surgery-acta Chirurgica Austriaca 42 ( 1) 24 -28
1
2010